Concepedia

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

Andrew Webb, David Cunningham, Finbarr E. Cotter, Paul A. Clarke, Francesca Di Stefano, Paul J. Ross, Margherita Corbo, Zofia E. Dziewanowska

The Lancet · 1997 · 498 citations · 17 references

DOI

Concepts

References

17

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

David M. Hockenbery, Gabriel Núñez, Curt Milliman et al. · Nature · 1990 · 3.8K citations

, , +13

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

Deborah J. Veis, Christine M. Sorenson, John R. Shutter et al. · Cell · 1993 · 1.6K citations

, , +8

bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.

Toshiyuki Miyashita, John C. Reed · PubMed · 1992 · 480 citations

, , +15

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Olivier Hermine, Corinne Haïoun, Éric Lepage et al. · Blood · 1996 · 417 citations · Full text

, , +11